Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Clinical trial NCT03474029 · RECRUITING
Trial details
- NCT number
- NCT03474029
- Sponsor
- Centers for Disease Control and Prevention
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2029-12-31
- Enrollment
- 3400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.